Basic Information
NUTRIFLEX® OMEGA SPECIAL B. BRAUN EMULSION FOR INFUSION
INJECTION, EMULSION
Regulatory Information
SIN16734P
March 7, 2023
Prescription Only
Therapeutic
INTRAVENOUS
August 10, 2023
June 4, 2025
XB05BA10
Company Information
Active Ingredients
Strength: 0.623g/1000ml
Strength: 158.4g/1000ml
Strength: 3.284g/1000ml
Strength: 3.604g/1000ml
Strength: 7.024mg/1000ml
Strength: 2.736g/1000ml
Strength: 3.689g/1000ml
Strength: 2.312g/1000ml
Strength: 4.200g/1000ml
Strength: 0.378g/1000ml
Strength: 4.908g/1000ml
Strength: 3.780g/1000ml
Strength: 4.916g/1000ml
Strength: 3.980g/1000ml
Strength: 16.00g/1000ml
Strength: 20.00g/1000ml
Strength: 0.800g/1000ml
Strength: 4.000g/1000ml
Strength: 0.910g/1000ml
Strength: 2.368g/1000ml
Strength: 2.100g/1000ml
Strength: 4.384g/1000ml
Strength: 4.760g/1000ml
Strength: 2.496g/1000ml
Strength: 2.540g/1000ml
Strength: 1.171g/1000ml
Strength: 0.250g/1000ml
Strength: 6.792g/1000ml
Detailed Information
Contraindications
**4.3 Contraindications** - hypersensitivity to the active substances, to egg, fish, peanut or soya protein or to any of the excipients listed in section 6.1 – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_ - inborn errors of amino acid metabolism - severe hypertriglyceridaemia (≥ 1000 mg/dL or 11.4 mmol/L) - severe coagulopathy - hyperglycaemia not responding to insulin doses of up to 6 units insulin/hour - acidosis - intrahepatic cholestasis - severe hepatic insufficiency - severe renal insufficiency in absence of renal replacement therapy - aggravating haemorrhagic diatheses - acute thromboembolic events, lipid embolism On account of its composition Nutriflex® Omega Special B. Braun Emulsion for Infusion must not be used in newborn infants, infants and toddlers under 2 years of age. General contraindications to parenteral nutrition include: - unstable circulatory status with vital threat (states of collapse and shock) - acute phases of cardiac infarction and stroke - unstable metabolic condition (e.g. severe postaggression syndrome, coma of unknown origin) - inadequate cellular oxygen supply - disturbances of the electrolyte and fluid balance - acute pulmonary oedema - decompensated cardiac insufficiency.
Indication Information
**4.1 Therapeutic indications** Supply of energy, essential fatty acids including omega-3 and omega-6 fatty acids, amino acids, electrolytes and fluids for parenteral nutrition of patients in states of moderate to severe catabolism when oral or enteral nutrition is impossible, insufficient or contraindicated. Nutriflex® Omega Special B. Braun Emulsion for Infusion is indicated in adults.